This article uses bare URLs, which are uninformative and vulnerable to link rot. Please consider converting them to full citations to ensure the article remains verifiable and maintains a consistent citation style. Several templates and tools are available to assist in formatting, such as reFill (documentation) and Citation bot (documentation).(August 2022) (Learn how and when to remove this message)
transmembrane receptor protein tyrosine kinase activity
protein tyrosine kinase activity
protein phosphatase binding
ATP binding
receptor tyrosine kinase
transmembrane signaling receptor activity
Cellular component
integral component of membrane
membrane
plasma membrane
cell surface
perinuclear region of cytoplasm
cytoplasm
integral component of plasma membrane
receptor complex
Biological process
cell differentiation
regulation of TOR signaling
signal transduction
phosphorylation
transmembrane receptor protein tyrosine kinase signaling pathway
regulation of phosphate transport
negative regulation of gene expression
protein phosphorylation
spermatogenesis
regulation of ERK1 and ERK2 cascade
peptidyl-tyrosine autophosphorylation
cell population proliferation
columnar/cuboidal epithelial cell development
regulation of cell growth
negative regulation of signal transduction
negative regulation of apoptotic process
positive regulation of ERK1 and ERK2 cascade
Sources:Amigo / QuickGO
Orthologs
Species
Human
Mouse
Entrez
6098
19886
Ensembl
ENSG00000047936
ENSMUSG00000019893
UniProt
P08922
Q78DX7
RefSeq (mRNA)
NM_002944 NM_001378891 NM_001378902
NM_011282
RefSeq (protein)
NP_002935 NP_001365820 NP_001365831
NP_035412
Location (UCSC)
Chr 6: 117.29 – 117.43 Mb
Chr 10: 51.92 – 52.07 Mb
PubMed search
[3]
[4]
Wikidata
View/Edit Human
View/Edit Mouse
Proto-oncogene tyrosine-protein kinase ROS is an enzyme that in humans is encoded by the ROS1 gene.[5][6]
^ abcGRCh38: Ensembl release 89: ENSG00000047936 – Ensembl, May 2017
^ abcGRCm38: Ensembl release 89: ENSMUSG00000019893 – Ensembl, May 2017
^"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^Galland F, Stefanova M, Lafage M, Birnbaum D (July 1992). "Localization of the 5' end of the MCF2 oncogene to human chromosome 15q15----q23". Cytogenetics and Cell Genetics. 60 (2): 114–6. doi:10.1159/000133316. PMID 1611909.
tyrosine-protein kinase ROS is an enzyme that in humans is encoded by the ROS1 gene. This proto-oncogene, highly expressed in a variety of tumor cell lines...
Repotrectinib is an inhibitor of proto-oncogene tyrosine-protein kinase ROS1 (ROS1) and of the tropomyosin receptor tyrosine kinases (TRKs) TRKA, TRKB, and...
under the brand name Rozlytrek, is an anti-cancer medication used to treat ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumors...
administered inhibitor of anaplastic lymphoma kinase (ALK) and C-ros oncogene 1 (ROS1), two enzymes that play a role in the development of cancer. It was developed...
amplifications. Also ROS1-positive tumors have shown high sensitivity to ALK inhibitors due to the high homology between the kinase domains of ROS1 and ALK. Immune...
malignant neoplasms. It also acts as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor. Crizotinib is indicated for the treatment of...
dabrafenib combined with the MEK inhibitor trametinib; those with activated ROS1 (around 1% of NSCLC) can be inhibited by crizotinib, lorlatinib, or entrectinib;...
Rohypnol (flunitrazepam), for severe insomnia. Rozlytrek (entrectinib), for ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumours...
response of the tumour and prognosis of the patient. Crizotinib (also a ROS1 and c-MET inhibitor) was approved in Aug 2011 by the US FDA for ALK-positive...
include fusions involving various kinases such as BRAF, RAF1, ALK, RET, ROS1, NTRK1., NTRK3 and MET BRAF, RAS, and NF1 mutations and kinase fusions are...
several other receptor tyrosine kinases such as MST1R, FLT3, AXL, MERTK, TEK, ROS1, NTRK1/2/3, and DDR1/2. Meristinib is part of a phase II clinical trial for...
adults with advanced non-small cell lung cancer (NSCLC) with no EGFR, ALK, or ROS1 aberrations. As of 2017[update], cemiplimab is being investigated for the...
PTK7 RYK receptor family RYK MuSK receptor family MUSK ROS receptor family ROS1 AATYK receptor family AATYK AATYK2 AXL receptor family AXL MER TYRO3 RET...
open-source operating system intended to be binary-compatible with Windows NT ROS1, receptor tyrosine kinase ROS, a weak signal sound card mode for Amateur...
PTK7 RYK receptor family RYK MuSK receptor family MUSK ROS receptor family ROS1 AATYK receptor family AATYK AATYK2 AXL receptor family AXL MER TYRO3 RET...
PTK7 RYK receptor family RYK MuSK receptor family MUSK ROS receptor family ROS1 AATYK receptor family AATYK AATYK2 AXL receptor family AXL MER TYRO3 RET...
et al. (April 2020). "New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1)". Current Oncology Reports. 22 (5): 48. doi:10.1007/s11912-020-00909-8....
PTK7 RYK receptor family RYK MuSK receptor family MUSK ROS receptor family ROS1 AATYK receptor family AATYK AATYK2 AXL receptor family AXL MER TYRO3 RET...
PTK7 RYK receptor family RYK MuSK receptor family MUSK ROS receptor family ROS1 AATYK receptor family AATYK AATYK2 AXL receptor family AXL MER TYRO3 RET...
PTK7 RYK receptor family RYK MuSK receptor family MUSK ROS receptor family ROS1 AATYK receptor family AATYK AATYK2 AXL receptor family AXL MER TYRO3 RET...
PTK7 RYK receptor family RYK MuSK receptor family MUSK ROS receptor family ROS1 AATYK receptor family AATYK AATYK2 AXL receptor family AXL MER TYRO3 RET...